Where can I listen to this podcast?

This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

Yes, this podcast regularly features guests.

CAPSTONE: An Exagen Podcast

Claim This Podcast

by Exagen Podcast

5.0(1 reviews)

4 episodes

Updated Daily

Accepts GuestsHas Sponsors

Podcast Overview

The CAPSTONE study is the largest ever comparative utility study in lupus diagnostics. But why was the study necessary to conduct? What did the process look like? And what do the results prove? Answering these questions are our two interviewees: Dr. Debra Zack, Chief Medical Officer for Exagen and Tyler O’Malley, Director of Evidence Development for Exagen and co-author of the study. Join them on this four-part journey as they explore the unmet need that prompted the study, the conclusive results from the study, and what these discoveries mean for both patients and providers.

Language

🇺🇲

Publishing Since

7/6/2022

Visit Website View on Apple Podcasts RSS Feed

Reach the team behind CAPSTONE: An Exagen Podcast

Verified contact details for this show aren't on file yet — sign up to get notified when they land.

Recent Episodes

July 6, 2022

Episode 4: The Questions

What are the highlights surrounding the CAPSTONE study? How does it prove that AVISE testing is improving the diagnostic odyssey? Join Dr. Debra Zack and Tyler O’Malley as they summarize the discoveries of the CAPSTONE study, highlight the key components, and expand on their thoughts on what this means for the future of lupus—and autoimmune—diagnostics.

July 6, 2022

Episode 3: The Application

The results of the CAPSTONE study are exciting and encouraging, but what do they mean for providers and patients from an application perspective? And what impact will this have on payors? Join Dr. Debra Zack and Tyler O’Malley as they take the results from the CAPSTONE study and apply them to the diagnostic journey for both patients and providers. From insurance coverage to timely and accurate diagnosis, they explore the implications of the study in real-time.

July 6, 2022

Episode 2: The Study

Conducting the largest utility study in lupus diagnostics means big numbers, a long timeline, and intriguing results. What was the methodology, conclusion, and results of the CAPSTONE study? Join Dr. Debra Zack and Tyler O’Malley as they breakdown the process of the study, expand on the patient cohorts, and go into detail on the conclusive evidence that showcases the superiority of the AVISE lupus test compared to current standard of care.

4 total episodes available

Deep-dive analytics for CAPSTONE: An Exagen Podcast

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is CAPSTONE: An Exagen Podcast?: The CAPSTONE study is the largest ever comparative utility study in lupus diagnostics. But why was the study necessary to conduct? What did the process look like? And what do the results prove?

Answering these questions are our two interviewees: Dr. Debra Zack, Chief Medical Officer for Exagen and Tyler O’Malley, Director of Evidence Development for Exagen and co-author of the study. Join them on this four-part journey as they explore the unmet need that prompted the study, the conclusive results from the study, and what these discoveries mean for both patients and providers.
How often does this podcast release new episodes?: This podcast updates daily.
Where can I listen to this podcast?: This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
Does this podcast accept guests?: Yes, this podcast regularly features guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.